Would drug makers lower their insulin prices if Congress asks nicely?

Stat News

29 April 2022 - After a year's long, drawn-out debate over how to best lower patients’ prescription drug prices, two senators are workshopping a new idea to slash insulin costs: dangling incentives to convince drug makers to lower prices of their own free will.

Read Stat News article 

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , US , Regulation , Pricing